Deep Brain Stimulation at Some Frequencies May Be as Effective as Medication for Parkinson’s Disease
A new study offers hope for improving DBS treatments.
For some patients with degenerative bone disorders, the human monoclonal antibody denosumab can reduce BMD loss and the risk for fractures. Ongoing research is revealing the advantages and risks.
In 2021, scientists continue to learn about diagnosis, treatment and prevention of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
A tailor-made oncology treatment, CAR T-cell therapy promises to transform cancer care. But can its potential overcome its problems?
Galleri, a test developed by California-based healthcare company Grail, can detect dozens of types of cancer — most of which currently lack a recommended screening test — with a single blood sample. What could that mean for the way clinicians screen for and treat cancer?
- 1 of 249
- next ›